March 2015
RoundTable Healthcare Partners Completes Sale of Tower Holdings, Inc. and Lineage Therapeutics, Inc. to Impax Laboratories, Inc.
LAKE FOREST, IL, March 10, 2015 – RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Tower Holdings, Inc. (“Tower”), including operating subsidiaries CorePharma LLC (“CorePharma”) and Amedra Pharmaceuticals LLC (“Amedra”), and Lineage Therapeutics Inc. (“Lineage”) (together, the “Companies”) to Impax Laboratories, Inc. (“Impax”) for $700 million in cash, subject to certain adjustments. Impax, headquartered in Hayward, California, is a specialty pharmaceutical company focused on the development of complex, high-value generics, and branded products that target central nervous system disorders and other select specialty segments.